ME1 and hepatocellular carcinoma: ME1 is also a poor prognostic factor for lipid metabolism in HCC [28,29], in which its overexpression can lead to epithelial–mesenchymal transition (EMT) [14] and anticancer drug resistance [30] in HCC.